Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

DNA methylation and gene expression changes during acquired resistance to ALK inhibitors (450k DNA methylation microarray)

ABSTRACT: DNA methylation and gene expression changes during acquired resistance to ALK inhibitors (450k DNA methylation microarray)

PROVIDER: PRJNA579537 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

DNA methylation and gene expression changes during acquired resistance to ALK inhibitors (450k DNA methylation microarray)

Project description:To identify novel mechanisms of acquired resistance to ALK inhibitors, we established in vitro models of acquired resistance to ceritinib using H3122 cell. In this study, we examined genome-wide DNA methylation changes during acquired resistance to ceritinib. We also examined the heterogeneity of parental and resistant cells using single cell RNA--seq.

2022-09-20 | GSE139387 | GEO

DNA methylation and gene expression changes during acquired resistance to ALK inhibitors (scRNA-seq)

2022-09-20 | GSE139386 | GEO

DNA methylation and gene expression changes during acquired resistance to ALK inhibitors

Project description:DNA methylation and gene expression changes during acquired resistance to ALK inhibitors

| PRJNA579530 | ENA

Methylation profiling study by MBD-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors

Project description:Treatment with ALK tyrosine kinase inhibitors often elicits profound initial antitumor responses in ALK fusion-positive patients with lung adenocarcinoma. However, patients invariably develop acquired resistance to ALK inhibitors. In this study, we aimed to identify molecular events that limit the response to ALK inhibition using genetic and epigenetic approaches. To identify novel mechanisms of acquired resistance to ALK inhibitors, we established in vitro models of acquired resistance to ceritinib using H3122 cell. For in vitro model, H3122 parental cells, ceritinib-treated resistant cells, and non-resistant cells that combinely treated with certinib and panobinostat were used for MBD-seq based methylation profiling.

2018-05-28 | GSE81483 | GEO

DNA methylation and gene expression changes during acquired resistance to ALK inhibitors (scRNA-seq)

Project description:DNA methylation and gene expression changes during acquired resistance to ALK inhibitors (scRNA-seq)

| PRJNA579536 | ENA

DNA methylation analysis in oropharyngeal cancer [450K array]

Project description:DNA methylation analysis in oropharyngeal cancer [450K array]

| PRJNA512095 | ENA

YAP activation mediates acquired resistance to ALK inhibitor in ALK rearranged non–small cell lung cancer

Project description:To investigate a possible candidate for overcoming the acquired resistance to ALK-TKI, we established an in vitro model of acquired resistance to crizotinib (H3122-CR) by exposing EML4-ALK–positive H3122 lung cancer cells to increasing doses of crizotinib.

2019-12-31 | GSE117181 | GEO

ICGC CLL 450k DNA methylation

Project description:DNA methylation of ICGC CLL patients measured by Illumina 450k array

| EGAD00010001975 | EGA

ChIP-seq for identifying molecules associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors

2018-05-28 | GSE81482 | GEO

DNA methylation profiling for 850k reannotation and normalization evaluation [450k]

Project description:DNA methylation profiling for 850k reannotation and normalization evaluation [450k]

| PRJNA816180 | ENA